Cargando…
Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
AIM: This study attempted to distinguish primary bladder adenocarcinoma (PBA) from metastatic colonic adenocarcinomas (MCA), which is a difficult diagnostic and clinical problem. METHODS: Twenty-four cases of bladder adenocarcinomas (12 primary & 12 metastatic colorectal) were included in the st...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502416/ https://www.ncbi.nlm.nih.gov/pubmed/23121893 http://dx.doi.org/10.1186/1746-1596-7-151 |
_version_ | 1782250333621190656 |
---|---|
author | Roy, Somak Smith, Matthew A Cieply, Kathy M Acquafondata, Marie B Parwani, Anil V |
author_facet | Roy, Somak Smith, Matthew A Cieply, Kathy M Acquafondata, Marie B Parwani, Anil V |
author_sort | Roy, Somak |
collection | PubMed |
description | AIM: This study attempted to distinguish primary bladder adenocarcinoma (PBA) from metastatic colonic adenocarcinomas (MCA), which is a difficult diagnostic and clinical problem. METHODS: Twenty-four cases of bladder adenocarcinomas (12 primary & 12 metastatic colorectal) were included in the study with urothelial carcinoma (UC) and colonic adenocarcinoma (CA) as controls. A panel of immunohistochemical (IHC) stains along with fluorescence in-situ hybridization (FISH), using the UroVysion probe set, was performed. RESULTS: The majority of the PBAs presented with advanced disease. Enteric histologic subtype was the most common morphological variant. Strong nuclear with cytoplasmic-membranous staining of β-catenin was seen in 75% of MCA and only 16.7% PBA (<10% staining cells). Although abnormal nuclear staining with E-cadherin was seen in both PBA and MCA, it was more frequent in former. CK-7, CK-20, villin and CDX-2 stains were not helpful in distinguishing the two entities. FISH did not reveal any unique differences in chromosomal abnormality between the two groups. CONCLUSION: Although there was a statistically significant difference in β-catenin and E-cadherin staining between two groups, we did not find any IHC or FISH marker that was specific for PBA. Distinction between PBA and MCA remains a diagnostic problem and clinical correlation is vital before rendering a diagnosis. VIRTUAL SLIDES: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1393156268152357 |
format | Online Article Text |
id | pubmed-3502416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35024162012-11-21 Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge Roy, Somak Smith, Matthew A Cieply, Kathy M Acquafondata, Marie B Parwani, Anil V Diagn Pathol Research AIM: This study attempted to distinguish primary bladder adenocarcinoma (PBA) from metastatic colonic adenocarcinomas (MCA), which is a difficult diagnostic and clinical problem. METHODS: Twenty-four cases of bladder adenocarcinomas (12 primary & 12 metastatic colorectal) were included in the study with urothelial carcinoma (UC) and colonic adenocarcinoma (CA) as controls. A panel of immunohistochemical (IHC) stains along with fluorescence in-situ hybridization (FISH), using the UroVysion probe set, was performed. RESULTS: The majority of the PBAs presented with advanced disease. Enteric histologic subtype was the most common morphological variant. Strong nuclear with cytoplasmic-membranous staining of β-catenin was seen in 75% of MCA and only 16.7% PBA (<10% staining cells). Although abnormal nuclear staining with E-cadherin was seen in both PBA and MCA, it was more frequent in former. CK-7, CK-20, villin and CDX-2 stains were not helpful in distinguishing the two entities. FISH did not reveal any unique differences in chromosomal abnormality between the two groups. CONCLUSION: Although there was a statistically significant difference in β-catenin and E-cadherin staining between two groups, we did not find any IHC or FISH marker that was specific for PBA. Distinction between PBA and MCA remains a diagnostic problem and clinical correlation is vital before rendering a diagnosis. VIRTUAL SLIDES: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1393156268152357 BioMed Central 2012-11-02 /pmc/articles/PMC3502416/ /pubmed/23121893 http://dx.doi.org/10.1186/1746-1596-7-151 Text en Copyright ©2012 Roy et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Roy, Somak Smith, Matthew A Cieply, Kathy M Acquafondata, Marie B Parwani, Anil V Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge |
title | Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge |
title_full | Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge |
title_fullStr | Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge |
title_full_unstemmed | Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge |
title_short | Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge |
title_sort | primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502416/ https://www.ncbi.nlm.nih.gov/pubmed/23121893 http://dx.doi.org/10.1186/1746-1596-7-151 |
work_keys_str_mv | AT roysomak primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge AT smithmatthewa primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge AT cieplykathym primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge AT acquafondatamarieb primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge AT parwanianilv primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge |